Probiotics in the Prevention and Treatment of Gastrointestinal Infections

Gastroenterology Clinics of North America

Volumn 35, Issue 2, 2006, Pages 355-365

  Huebner, Elizabeth S ^a   Surawicz, Christina M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

299 V; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BB 12; BETA LACTAM ANTIBIOTIC; BIOFLORIN; CD 2; CLARITHROMYCIN; CLINDAMYCIN; DN 114001; ERYTHROMYCIN; LA 5; LACTINEX; METRONIDAZOLE; NEOMYCIN; NITRAZEPAM; OLL 2716; OMEPRAZOLE; PLACEBO; PROBIOTIC AGENT; RABEPRAZOLE; UNCLASSIFIED DRUG; VANCOMYCIN; YOGHURT;

ACUTE DIARRHEA; ACUTE PANCREATITIS; ANTIBIOTIC RESISTANCE; BLOATING; CLINICAL TRIAL; DIARRHEA; DIGESTIVE SYSTEM INFECTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ERADICATION THERAPY; GASTRITIS; GASTROINTESTINAL INFECTION; HEALTH CARE COST; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LACTOBACILLUS; LOW DRUG DOSE; NAUSEA; NONHUMAN; PANCREAS DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; SACCHAROMYCES BOULARDII; TASTE DISORDER; TRAVELLER DIARRHEA;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFANT; PROBIOTICS; TRAVEL;

EID: 33746332362     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2006.03.005     Document Type: Review

References (77)

1. Metchnikoff E. The prolongation of life (1908), Putnam's Sons, London
2. FAO/WHO. Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Expert Consultation Report: Cordoba, Argentina: Food and Agriculture Organization of the United Nations and World Health Organization, October 2001.
3. Rolfe R.D. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 183 (2000) 396S-402S
4. Aiba Y., Suzuki N., Kabir A.M.A., et al. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 93 11 (1998) 2097-2101
5. Lorca G.L., Wadström T., Font de Valdez G., et al. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 42 1 (2001) 39-44
6. Pinchuk I.V., Bressollier P., Verneuil B., et al. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 45 11 (2001) 3156-3161
7. Nam H., Ha M., Bae O., and Lee Y. Effect of Weissella confusa strain PL9001 on the adherence and growth of Helicobacter pylori. Appl Environ Microbiol 68 9 (2002) 4642-4645
8. Mukai T., Asasaka T., Sato E., et al. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol 32 2 (2002) 105-110
9. Michetti P., Dorta G., Wiesel P.H., et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La on Helicobacter pylori infection in humans. Digestion 60 3 (1999) 203-209
10. Gotteland M., and Cruchet S. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J Antimicrob Chemother 51 5 (2003) 1317-1319
11. Cruchet S., Obregon M.C., Salazar G., et al. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 19 9 (2003) 716-721
12. Felley C.P., Corthesy-Theulaz I., Rivero J.L., et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 13 1 (2001) 25-29
13. Pantoflickova D., Corthesy-Theulaz I., Dorta G., et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori-associated gastritis. Aliment Pharmacol Ther 18 8 (2003) 805-813
14. Linsalata M., Russo F., Berloco P., et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 9 2 (2004) 165-172
15. Wang K.Y., Li S.N., Liu C.S., et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 80 3 (2004) 737-741
16. Cats A., Kuipers E.J., Bosschaert M.A., et al. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 17 3 (2003) 429-435
17. Sakamoto I., Igarashi M., Kimura K., et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 47 5 (2001) 709-710
18. Shimizu T., Haruna H., Hisada K., et al. Effects of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in children. J Antimicrob Chemother 50 4 (2002) 617-618
19. Canducci F., Armuzzi A., Cremonini F., et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14 12 (2000) 1625-1629
20. Sheu B.S., Wu J.J., Lo C.Y., et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 16 9 (2002) 1669-1675
21. Sykora J., Valeckova K., Amlerova J., et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 39 8 (2005) 692-698
22. Tursi A., Brandimarte G., Giorgetti G.M., et al. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 10 (2004) CR662-CR666
23. Wendakoon C.N., Thomson A.B.R., and Ozimek L. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion 61 1 (2002) 16-20
24. Armuzzi A., Cremonini F., Ojetti V., et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 63 1 (2001) 1-7
25. Armuzzi A., Cremonini F., Bartolozzi F., et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 15 2 (2001) 163-169
26. Cremonini F., Di Caro S., Covino M., et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97 11 (2002) 2744-2749
27. Nista E.C., Candelli M., Cremonini F., et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 20 10 (2004) 1181-1188
28. Myllyluoma E., Veijola L., Ahlroos T., et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 21 10 (2005) 1263-1272
29. Kollaritsch H., Holst H., Grobara P., et al. Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study. Fortschr Med 111 9 (1993) 152-156
30. Black F.T., Andersen P.L., Orskov J., et al. Prophylactic efficacy of lactobacilli on traveler's diarrhea. J Travel Med 7 (1989) 333-335
31. Oksanen P.J., Salminen S., Saxelin M., et al. Prevention of travelers' diarrhoea by Lactobacillus GG. Ann Med 22 1 (1990) 53-56
32. Hilton E., Kolakowski P., Singer C., et al. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 4 1 (1997) 41-43
33. De dios Pozo-Olano J., Warram Jr. J.H., Gomez R.G., et al. Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial. Gastroenterology 74 5 (1978) 829-830
34. McFarland L.V. Epidemiology, risk factors and treatments for antibiotic associated diarrhea. Dig Dis 16 5 (1998) 292-307
35. D'Souza A.L., Rajkumar C., Cooke J., et al. Probiotics in prevention of antibiotic associated diarrhea: meta-analysis. BMJ 324 7350 (2002) 1361
36. Szajewska H., and Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 22 5 (2005) 365-372
37. Siitonen S., Vapaatalo H., Salminen S., et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea. Ann Med 22 1 (1990) 57-59
38. Arvola T., Laiho K., Torkkeli S., et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 104 5 (1999) e64
39. Vanderhoof J.A., Whitney D.B., Antonson D.L., et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135 5 (1999) 564-568
40. Thomas M.R., Litin S.C., Osmon D.R., et al. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc 76 9 (2001) 883-889
41. Gotz V., Romankiewicz J.A., Moss J., et al. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 36 6 (1979) 754-757
42. Tankanow R.M., Ross M.B., Ertel I.J., et al. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP 24 4 (1990) 382-384
43. Clements M.L., Levine M.M., Ristaino P.A., et al. Exogenous lactobacilli fed to man-their fate and ability to prevent diarrheal disease. Prog Food Nutr Sci 7 3-4 (1983) 29-37
44. Adam J., Barret C., Barret-Bellet A., et al. Double blind controlled trial of lyphilized Ultra-Levure. Multicenter study by 26 physicians of 386 cases. Gaz Med Fr 84 (1977) 2072-2081
45. Surawicz C.M., Elmer G.W., Speelman P., et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96 4 (1989) 981-988
46. McFarland L.V., Surawicz C.M., Greenberg R.N., et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 90 3 (1995) 439-448
47. Bleichner G., Blehaut H., Mentec H., et al. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 23 5 (1997) 517-523
48. Duman D.G., Bor S., Ozutemiz O., et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 17 12 (2005) 1357-1361
49. Lewis S.J., Potts L.F., and Barry R.E. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhea in elderly patients. J Infect 37 3 (1998) 307-308
50. Kotowska M., Albrecht P., and Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 21 5 (2005) 583-590
51. Wunderlich P.F., Braun L., Fumagalli I., et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhea and in the treatment of acute diarrhea. J Int Med Res 17 4 (1989) 333-338
52. Borgia M., Sepe N., Brancato V., et al. A controlled clinical study on Streptococcus faecium preparation for the prevention of side reactions during long-term antibiotic treatments. Curr Ther Res 31 (1982) 266-271
53. Orrhage K., Brignar B., and Nord C.E. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb Ecol Health Dis 7 (1994) 17-25
54. Colombel J.F., Cortot A., Neut C., et al. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 2 8549 (1987) 43
55. Elmer G.W., and McFarland L.V. Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters. Antimicrob Agents Chemother 31 (1987) 129-131
56. Surawicz C.M., McFarland L.V., Elmer G., et al. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 84 10 (1989) 1285-1287
57. Popoola J., Swann A., and Warwick G. Clostridium difficile in patients with renal failure - management of an outbreak using biotherapy. Nephrol Dial Transplant 15 5 (2000) 571-574
58. McFarland L.V., Surawicz C.M., Greenberg R.N., et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271 24 (1994) 1913-1918
59. Surawicz C.M., McFarland L.V., Greenberg R.N., et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31 4 (2000) 1012-1017
60. Gorbach S.L., Chang T.W., and Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 2 (1987) 1519
61. Biller J.A., Katz A.J., Flores A.F., et al. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 21 2 (1995) 224-226
62. Bennett RG, Laughon B, Lindsay J, et al. Lactobacillus GG treatment of Clostridium difficile infection in nursing home patients. Presented at the 3rd International Conference on Nosocomial Infection. Atlanta, July 31-August 3, 1990.
63. Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 95 (2000) S11-S13
64. Wullt M., Hagslatt M.J., and Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 35 (2003) 365-367
65. Schwan A., Sjölin S., Trottestam U., et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 16 (1984) 211-215
66. Bowden T.A., Mansberger A.R., and Lykins L.E. Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. Am Surg 47 (1981) 178-183
67. Persky S.E., and Brandt L.J. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 95 11 (2000) 3283-3285
68. Aas J., Gessert C.E., and Bakken J.S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 36 (2003) 580-585
69. Tvede M., and Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1 8648 (1989) 1156-1160
70. Seal D., Borriello S.P., Barclay F., et al. Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur J Clin Microbiol 6 (1987) 51-53
71. Mangiante G., Colucci G., Canepari P., et al. Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis. Dig Surg 18 (2001) 47-50
72. Akyol S., Mas M.R., Comert B., et al. The effect of antibiotic and probiotic combination therapy on secondary pancreatic infections and oxidative stress parameters in experimental acute necrotizing pancreatitis. Pancreas 26 4 (2003) 363-367
73. Olah A., Belagyi T., Issekutz A., et al. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89 9 (2002) 1103-1107
74. Olah A., Belagvi T., Issekutz A., et al. Combination of early nasojejunal feeding with modern symbiotic therapy in the treatment of severe acute pancreatitis (prospective, randomized, double-blind study). Magy Seb 58 3 (2005) 173-178
75. Besselink M.G.H., Timmerman H.M., Buskens E., et al. Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomized multicenter trial. BMC Surg 4 1 (2004) 12
76. Vanderhoof J.A., and Young R.J. Pediatric applications of probiotics. Gastroenterol Clin North Am 34 (2005) 451-463
77. Huang J.S., Bousvaros A., Lee J.W., et al. Efficacy of probiotic use in acute diarrhea in children. A meta-analysis. Dig Dis Sci 47 11 (2002) 2625-2634